Key result
Secondary prevention measures and risk factor modification in patients with coronary heart disease remain inadequately implemented in clinical practice, with high prevalences of adverse lifestyle characteristics and underuse of prophylactic drugs.
Despite established guidelines, there remains a significant global gap in the implementation of secondary prevention measures and risk factor control for patients with coronary heart disease in everyday clinical practice.
Ongoing CHD secondary prevention gaps warrant clinical attention; leaves open effective strategies to improve implementation.
Recommendations for prevention of coronary heart disease are measures that are available to both individuals and entire populations to detect diseases and faster and more successful intervention, respectively a measure directed against the progression or recurrence of diseases in people with established disease. Secondary prevention of coronary heart disease seemed to measures aimed at preventing relapses and progression of atherosclerosis in people who already have developed disease. Modification of coronary risk factors is a key part of secondary prevention of coronary bolesti. The main risk factors remain important predictors of long-term prognosis in patients with coronary artery disease. New studies on the application of measures of secondary prevention of coronary heart disease showed a high prevalence of adverse lifestyle characteristics, other risk factors and inadequate use of prophylactic drugs in patients with coronary disease. Inadequate treatment of risk factors in coronary patients is similar in Europe and other parts of the world.
No takes yet. Share an insight, caveat, or question.
Duško Vulić (2013) conducted a review in Coronary heart disease. Secondary prevention measures was evaluated. Secondary prevention measures and risk factor modification in patients with coronary heart disease remain inadequately implemented in clinical practice, with high prevalences of adverse lifestyle characteristics and underuse of prophylactic drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: